Quote For Human Genome Sciences, Inc. HGSI.O
Human Genome Sciences, Inc. (HGSI.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare ·
industry: Biotechnology ·
$27.11
27 Nov 2009
-3.04%
$27.96
$27.08
1,585,499
$27.68
$27.00
$29.48
$0.45
5.27
4,685,441
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Karabelas, Argeris | Chairman of the Board | -- |
| Watkins, H. Thomas | President, Chief Executive Officer, Director | 3,427,740 |
| Barabe, Timothy | Chief Financial Officer, Senior Vice President | 968,958 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $4,473.46 |
| Shares Outstanding (Mil.) | 165.01 |
| Float (Mil.) | 163.40 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 0.56 |
| Current Ratio | 4.07 |
| LT Debt/Equity | 210.41 |
| Total Debt/Equity | 210.41 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | 18.98 |
| Price/Book(TTM) | 15.89 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-0.25 |
| Sales(TTM) | $1.60 |
| Book Value(MRQ) | $1.71 |
| Cash Flow(TTM) | $-0.13 |
| Cash(MRQ) | $2.48 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -97.57 |
| Return on Assets(TTM) | -4.62 |
| Return on Investment(TTM) | -5.39 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | -- |
| Operating Margin(TTM) % | -2.83 |
| Profit Margin(TTM) % | -17.10 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
